Early diagnosis and appropriate treatment of primary aldosteronism, the most frequent
cause of secondary hypertension, are crucial to prevent deleterious cardiovascular …

Secondary diabetes mellitus is frequently ignored in specialized literature. In this narrative
review, the main endocrinopathies accompanied by increased glycemic values are …

Objective: To develop clinical practice guidelines for the management of patients with
primary aldosteronism. Participants: The Task Force included a chair, selected by the …

Hypertension is the most important modifiable cause of cardiovascular (CV) disease and all-
cause mortality worldwide. Despite the positive correlations between blood pressure (BP) …

Primary aldosteronism (PA) is a common cause of secondary hypertension and is
associated with worse cardiovascular outcomes. The elevated aldosterone in PA leads to …

Background In patients with primary aldosteronism (PA), long-term cardiovascular and
mortality outcomes after adrenalectomy vs mineralocorticoid receptor antagonist (MRA) …

Obese individuals frequently develop hypertension, which is for an important part
attributable to renin-angiotensin-aldosterone system (RAAS) overactivity. This review …

There exists a great knowledge gap in terms of long-term effects of various surgical and
pharmacological treatments on outcomes among primary aldosteronism (PA) patients. Using …

Aims An excess of aldosterone results in cardiac remodelling and fibrosis. Interleukin-6 (IL-
6) is a key mediator in the fibrotic process; however, the effect of aldosterone on the …

Arterial stiffness is recognized as a risk factor for many cardiovascular diseases. Aldosterone
via its binding to and activation of the mineralocorticoid receptors (MRs) is a main regulator …